A Study To Investigate The Safety And Metabolism Of GSK376501 In Overweight Subjects

Summary

This study represents the first administration of GSK376501 in humans and the goal is to evaluate its initial safety and tolerability. The way the human body processes GSK376501 will also be determined.

Timeline

Start

2006-10

Primary completion

2007-05

Completion

2007-05

Drugs

Indications